Glens Falls Association for the Blind, Inc.

06/24/2026

Executive Summary: Researchers at the Chinese University of Hong Kong (CUHK) Faculty of Medicine announced a major breakthrough in neuroprotective glaucoma treatment. By inhibiting a specific ocular protein receptor—Growth Hormone-Releasing Hormone Receptor (GHRHR)—the team successfully prevented optic nerve death and restored nearly 70% of lost vision in experimental animal models.

Key Findings & Mechanism:
* Targeted Pathway: The therapy blocks GHRHR in eye tissues, directly halting ferroptosis—an iron-dependent form of cell death responsible for destroying Retinal Ganglion Cells (RGCs).
* Optic Nerve Protection: Inhibiting this protein increased RGC survival rates by nearly 50% and reactivated vital visual signal transmissions.
* Vision Restoration: Unlike current treatments that only lower eye pressure to slow disease progression, this neuroendocrine approach actively reversed damage, restoring 70% of visual function (measured via light-avoidance behavior).

Public Availability Timeline: The research is currently in its early preclinical stages. According to the lead investigators at CUHK:
* Clinical Trials: Transitioning this therapy from animal models to human clinical trials is projected to take 5 to 7 years.
* Public Release: A commercial, widely available treatment is estimated to be 10 to 15 years away, pending rigorous human safety and efficacy testing.

06/21/2026

Photo for the luncheon and birthday celebration

06/19/2026

Please watch video

Source:https://www.podbean.com/eau/pb-dbamy-1ac0e09In this episode of The Blind Life Podcast, I sit down with Joan Jaeger from Hadley to talk about the emoti...

06/14/2026

Please watch video

Interested in getting credit for this lesson? Take the full AI Boost Bootcamp course on Google Skills and earn your badge → https://goo.gle/4ccw2mHLearn to w...

06/08/2026

https://www.youtube.com/watch?v=nuShREPizck

06/02/2026

Here are five things families should do for a blind person:
* Keep doors either fully open or fully shut to prevent them from walking into an edge.
* Announce yourself when entering or leaving a room.
* Use specific directions like "on your left" instead of saying "over there."
* Narrate your actions, such as when you are moving a glass or putting something down.
* Always return items to their designated "home base" so they can be found easily.

06/01/2026

Don’t Turn a Blind Eye to Safety! 👁️🛡️

June is National Safety Month, and your vision is the MVP. Whether you’re tackling DIY home projects or just enjoying the summer sun, your eyes are under fire from "the sting" of debris, UV rays, and digital strain.

How to Play it Safe:
* Suit Up: Wear ANSI-approved safety glasses for mowing, power tools, or cleaning with chemicals. A split-second accident can last a lifetime.
* Stop the Screen Sting: Give your eyes a break from the glare. Use the 20-20-20 rule to prevent digital fatigue.
* Sun Shield: High-quality sunglasses aren't just a fashion statement—they're a barrier against permanent UV damage.
* The 2-Year Rule: If you haven’t had a dilated eye exam in the last two years, June is your month to get it on the calendar.

Protect what you see. Stay safe out there!

05/30/2026

Clinical Report: The Impact of Outdoor Exposure and Visual Habits on Pediatric Myopia
​Subject: Prevention and Management of Childhood Myopia (Nearsightedness)
Core Recommendation: 2 Hours of Daily Outdoor Activity & Adherence to the 20-20-20 Rule
​1. The "2-Hour Rule": Why Outdoor Light is Essential
​Pediatricians and ophthalmologists increasingly recommend that children spend at least 120 minutes (2 hours) per day outdoors. This recommendation is rooted in the "Dopamine Hypothesis."
​Retinal Dopamine Release: Natural sunlight is significantly brighter than indoor lighting (even on a cloudy day). When this bright light hits the retina, it triggers the release of dopamine.
​The "Brake" Mechanism: Dopamine acts as a natural signal to the eye to stop growing. In myopia, the eyeball becomes too long (axial elongation), causing light to focus in front of the retina rather than on it. Retinal dopamine serves as a "brake" that prevents the eye from stretching out too far.
​Light Intensity: Indoor lighting typically ranges from 100 to 500 lux, whereas outdoor light can exceed 10,000 to 100,000 lux. Research suggests that the sheer intensity of outdoor light is the primary protective factor, regardless of whether the child is playing sports or simply sitting in the shade.
​2. The Risks of "Near-Work" and Indoor Habitats
​The "nearsightedness epidemic" is largely attributed to environmental shifts toward prolonged indoor activities.
​Peripheral Defocus: Indoors, our visual field is limited by walls and ceilings. Constant "near-work"—such as reading, using tablets, or playing video games—requires the eye to maintain a high state of focus (accommodation).
​Pupil Constriction: When children focus on close objects in dim indoor light, their pupils constrict to sharpen the image. New research suggests this combination significantly reduces the amount of light reaching the retina, which may weaken neural pathways that regulate eye growth.
​Physical Inactivity: Being indoors often correlates with stationary behavior. Outdoors, children naturally practice "distant gazing," which allows the eye muscles to relax and resets the visual system.
​3. The 20-20-20 Rule for Digital Devices
​To mitigate the strain caused by tablets and screens, pediatricians advocate for the 20-20-20 Rule to prevent "Digital Eye Strain" and reduce myopic progression:
​Every 20 Minutes: Set a timer or use a reminder.
​Look 20 Feet Away: Look at a distant object (like a tree outside the window).
​For 20 Seconds: This is the minimum time required for the intraocular muscles to fully relax.
​Note: Many specialists also recommend a 2-20 Rule: For every 2 hours of total screen time, children should take a full 20-minute break for physical movement.
​Summary of Benefits

05/29/2026

Medical Research Report: Photosynthetic Therapy for Dry Eye Disease

The Discovery:
Researchers at the National University of Singapore have successfully integrated plant-based photosynthetic machinery into human corneal cells. By extracting thylakoids from spinach and wrapping them in a protective "nano-shell," they created a delivery system that enters the eye and sets up microscopic energy factories.

How It Functions:
* Solar-Powered Healing: Once the drops are applied, ambient light triggers photosynthesis within the eye.
* Energy Production: The process generates ATP and NADPH, which are essential chemical "fuels."
* Cellular Repair: This boost in energy reduces inflammation and repairs the eye's natural ability to maintain moisture, rather than just providing temporary artificial tears.

Performance and Timeline:
* Efficacy: In preclinical trials, corneal damage was reversed in just 5 days.
* Next Steps: The team is currently moving toward human clinical trials.
* Availability: While not yet on the market, this treatment is a major shift toward "living" medicine for chronic eye conditions.

05/27/2026

Recent advancements in 2025 and 2026 have introduced several new eye drops, primarily targeting presbyopia (age-related blurry near vision) and dry eye.

# # # Presbyopia (Reading Vision)
Several new options now allow you to skip reading glasses for up to 10 hours:
* Yuvezzi: Approved in January 2026, it is the first dual-agent drop (carbachol and brimonidine). It improves near vision without blurring your distance vision and is rolling out in Q2 2026.
* Vizz (Aceclidine): Approved in late 2025, this once-daily drop uses a "pupil-selective" formula to sharpen focus with minimal side effects.
* Qlosi: A lower-dose pilocarpine (0.4%) option designed for flexibility, allowing a second dose later in the day if needed.

# # # Dry Eye & Other Treatments
* Tryptyr (Acoltremon): Launched in late 2025, this drop treats Dry Eye Disease (DED) by triggering natural tear production faster than traditional anti-inflammatories.
* MR-141: Currently under FDA review (expected October 2026), this drop aims to treat presbyopia by relaxing specific eye muscles rather than just shrinking the pupil.

Note: These are prescription-only. If you're tired of readers, Yuvezzi and Vizz are the newest big names to discuss with an optometrist.